Edgestream Partners, L.P. Arrowhead Pharmaceuticals, Inc. Transaction History
Edgestream Partners, L.P.
- $2.88 Billion
- Q1 2025
A detailed history of Edgestream Partners, L.P. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 305,507 shares of ARWR stock, worth $5.06 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
305,507
Previous 120,411
153.72%
Holding current value
$5.06 Million
Previous $2.26 Million
71.98%
% of portfolio
0.14%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$260 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$219 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$184 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$116 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$86.7 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.75B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...